Clinical & Operational Evidence
Evidence Behind the Post-Discharge Visibility Gap
MedSafe Follow-Up is informed by published evidence on medication safety, patient understanding, care transitions, post-discharge adverse events, and hospital readmissions. This Evidence Center summarizes selected research supporting the clinical and operational rationale for greater visibility after discharge.
Qualification: The studies below do not evaluate MedSafe Follow-Up itself and should not be interpreted as evidence that MedSafe independently reduces readmissions, prevents adverse events, or produces a specific financial outcome.
Theme A
Understanding After Discharge
Documented discharge education does not necessarily establish successful real-world medication understanding or execution.
Journal of General Internal Medicine · 2026
Anderson TS, Wilson LM, Wang BX, et al.
Medication Errors and Gaps in Medication Discharge Planning for Hospitalized Older Adults: A Prospective Cohort Study
In a prospective cohort of older adults with cardiometabolic medication changes, 93% reported understanding medication purpose at discharge, while 39% had at least one medication error seven days later. Comprehensive discharge planning was reported for only 13% of medication changes.
Limitation: Findings describe one prospective cohort of older adults with cardiometabolic medication changes and are not a universal discharge-education outcome.
View SourceAgency for Healthcare Research and Quality (AHRQ) · Health Literacy Universal Precautions Toolkit
Use the Teach-Back Method: Tool #5
AHRQ recommends verifying patient understanding through teach-back — asking patients to restate information in their own words — rather than relying only on yes/no confirmation of understanding.
View SourceTheme B
Medication Problems After Discharge
Post-discharge medication problems are documented across many settings, though how they are measured varies widely.
Drug Safety · 2020
Alqenae FA, Steinke D, Keers RN.
Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review
Across heterogeneous studies, post-discharge medication errors, unintentional discrepancies, and adverse drug events were common. Reported rates varied substantially by population, setting, definitions, and follow-up period.
Limitation: Heterogeneous studies, settings, and definitions. No single percentage should be treated as universally representative.
View SourceTheme C
Medication-Related Readmissions
A portion of early readmissions has been classified as medication-related, and some of that portion has been assessed as potentially preventable.
Frontiers in Pharmacology · 2021
Uitvlugt EB, et al.
Medication-Related Hospital Readmissions Within 30 Days of Discharge: Prevalence, Preventability, Type of Medication Errors and Risk Factors
In this prospective analysis, 16% of 30-day readmissions were classified as medication-related, and 40% of those medication-related readmissions were considered potentially preventable.
Limitation: These findings come from the study population and should not be interpreted as a universal hospital readmission rate or a predicted MedSafe effect.
View SourceTheme D
Care-Transition Interventions
Transition programs vary in design and reported effectiveness; the programs associated with lower readmission rates were typically multi-component.
International Journal of Clinical Pharmacy · 2025
Weber C, Meyer-Massetti C, Schönenberger N.
Pharmacist-led interventions at hospital discharge: a scoping review of studies demonstrating reduced readmission rates
Programs associated with lower readmissions frequently combined medication reconciliation, counseling, and post-discharge follow-up rather than relying on a single intervention. Intervention designs and study quality varied.
Limitation: Scoping review of heterogeneous interventions. The findings describe patterns across programs and do not validate any specific platform or product.
View SourceWhy the 30-Day Window Matters
The first 30 days after discharge are an established measurement window for hospital quality and utilization programs.
Centers for Medicare & Medicaid Services (CMS) · Ongoing program
Hospital Readmissions Reduction Program (HRRP)
CMS continues to use 30-day risk-standardized unplanned readmission measures within HRRP for designated conditions and procedures. This makes the first 30 days after discharge operationally relevant to hospital quality and utilization measurement, while not implying that every readmission is avoidable or medication-related.
Limitation: Program requirements and measure specifications are maintained by CMS and may change. This summary contains no reimbursement estimates.
View SourceFrom Evidence to Workflow
The published literature establishes the clinical rationale for understanding verification, barrier identification, structured transition support, and measurement. MedSafe Follow-Up applies these principles through a hospital-facing workflow; the product’s own effectiveness should be evaluated through organization-specific pilot results rather than inferred from third-party studies.
Identify
Prioritize & Route
Resolve
Measure
Evaluate the Evidence in Your Own Workflow
MedSafe Follow-Up hospital pilots are designed to help organizations evaluate patient engagement, understanding, barrier detection, follow-up workload, resolution, patient-reported support, and 30-day outcomes within their own care environment.